National Institutes of Health

Description

This funding opportunity announcement (FOA) requests U01 applications proposing a single, pragmatic clinical trial in adults with chronic pulmonary diseases. Each successful applicant will serve as a Protocol Leadership Group (PLG) for a new type of clinical research network: the Pulmonary Trials Cooperative (PTC). The PTC is a cooperative program that includes multiple PLGs and a Network Management Core (NEMO). The PTC is designed to conduct multiple clinical trials in both inpatient and outpatient settings in adults with a variety of chronic pulmonary diseases, including but not limited to interstitial lung disease (ILD), pulmonary hypertension (PH), chronic obstructive pulmonary disease (COPD), sarcoidosis, and obstructive sleep apnea, but excluding asthma and acute lung injury and critical care. Studies, which may include both Phase 2 and Phase 3 simple, pragmatic clinical trials, will evaluate the efficacy or effectiveness of promising new or existing therapies. This FOA solicits applications for PLGs, which will have primary responsibility for developing a protocol and supporting a Lead Investigator for that protocol in the conduct and analyses of the related trial. A companion FOA (RFA-HL-15-016) requests applications for NEMO.

Who can apply

• State governments
• County governments
• City or township governments
• Special district governments
• Independent school districts
• Public and State controlled institutions of higher education
• Native American tribal governments (Federally recognized)
• Public housing authorities / Indian housing authorities
• Native American tribal organizations (other than Federally recognized)
• Nonprofits with 501(c)(3) status (other than higher education)
• Nonprofits without 501(c)(3) status (other than higher education)
• Private institutions of higher education
• For-profit organizations other than small businesses
• Small businesses
• Others

Contact

NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV